Abstract
The main characteristic of Alzheimer's disease (AD) is brain deposition of the β-amyloid (Aβ) peptide, generated endoproteolytically from Aβ precursor protein (APP) by β- and γ-secretases. A transmembrane aspartyl protease, β-APP-cleaving enzyme (BACE1), was identified as β-secretase. Although BACE1 cleaves APP at the β-secretase site, the role of its homolog, β-secretase 2 (BACE2) is poorly understood. We report them RNA expression profile, DNA sequence, and molecular characterization of the BACE2 gene, located on chromosome 21q22.3. The BACE2 gene expresses more strongly in peripheral tissues, although BACE2 mRNA is found in the majority of brain regions, including the postcentral gyrus and temporal lobe. Characterization of 2932 bp of the BACE2 5′-flanking region (GC content of 55%), reveals the absence of canonical CCAAT and TATA boxes within 1 kb of the transcription start site (TSS). The sequence lacks significant internal repeats and has a housekeeping gene structure. Two active regions of the BACE2 promoter determine its basal expression and cell-type specificity. The proximal region (−31/+238) likely determines general basal expression, and the distal region (−2618/−1513), cell-type specificity. Several putative transcription factor sites, particularly SP1, Oct-1, and HES-1, are predicted to be within 1 kb of the TSS. On either side of the proximal promoter region, two negative regulatory domains might reduce BACE2 expression under an induced condition. The BACE2 5′-flanking region is likely to be highly regulated and expressed in a tissue type-specific manner.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Acquati F., Accarino M., Nucci C., Fumagalli P., Jovine L., Ottolenghi S., and Taramelli R. (2000) The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region. FEBS Lett. 468, 59–64.
Armstrong R.A., Cairns N.J., Myers D., Smith C.U., Lantos P.L., and Rossor M.N. (1996) A comparison of β-amyloid deposition in the medial temporal lobe in sporadic Alzheimer's disease, Down's syndrome and normal elderly brains. Neurodegeneration 5, 35–41.
Barbiero L., Benussi L., Ghidoni R., Alberici A., Russo C., Schettini G., et al. (2003) BACE-2 is overexpressed in Down's syndrome. Exp. Neurol. 182, 335–345.
Basi G., Frigon N., Barbour R., Doan, T. Gordon G., McConlogue L., et al. (2003) Antagonistic effects of β-site amyloid precursor protein-cleaving enzymes 1 and 2 on β-amyloid peptide production in cells. J. Biol. Chem. 278, 31,512–31,520.
Bennett B. D., Babu-Khan S., Loeloff R., Louis J. C., Curran E., Citron M., and Vassar R. (2000) Expression analysis of BACE2 in brain and peripheral tissues. J. Biol. Chem. 275, 20,647–20,651.
Bigl M., Apelt J., Luschekina E. A., Lange-Dohna C., Rossner S., and Schliebs R. (2000) Expression of β-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology. Neurosci. Lett. 292, 107–110.
Cai H., Wang Y., McCarthy D., Wen H., Borchelt D. R., Price D. L., and Wong P. C. (2001) BACE1 is the major β-secretase for generation of Aβ peptides by neurons. Nat. Neurosci. 4, 233–234.
Cai X. D., Golde T. E., and Younkin S. G. (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514–516.
Christensen M. A., Zhou W., Qing H., Lehman A., Philipsen S., and Song W. (2004) Transcriptional regulation of BACE1, the β-amyloid precursor protein β-secretase, by Sp1. Mol. Cell. Biol. 24, 865–874.
Citron M., Vigo-Pelfrey C., Teplow D. B., Miller C., Schenk D., Johnston J., et al. (1994) Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl. Acad. Sci. U. S. A. 91, 11,993–11,997.
Clarimon J., Bertranpetit J., Calafell F., Boada M., Tarraga L., and Comas D. (2003) Association study between Alzheimer's disease and genes involved in Aβ biosynthesis, aggregation and degradation: suggestive results with BACE1. J. Neurol. 250, 956–961.
Farzan M., Schnitzler C. E., Vasilieva N., Leung D., and Choe H. (2000) BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein. Proc. Natl. Acad. Sci. U. S. A. 97, 9712–9717.
Fluhrer R., Capell A., Westmeyer G., Willem M., hartung B., Condron M. M., et al (2002) Anon-amyloidogenic function of BACE-2 in the secretory pathway. J. Neurochem. 81, 1011–1020.
Ge Y. W., Maloney B., Sambamurti K., and Lahiri D. K. (2004) Functional characterization of the 5′ flanking region of the BACE gene: identification of a 91 bp fragment involved in basal level of BACE promoter expression. FASEB J. 18, 1037–1039.
Ghosh C. and Lahiri D. K. (1999) Increased vulnerability of neuronal cell lines to sodium nitroprusside-mediated toxicity is caused by the decreased level of nitric oxide metabolites. J. Mol. Neurosci. 13, 77–92.
Ghosh C., Song W., and Lahiri D. K. (2000) Efficient DNA transfection in neuronal and astrocytic cell lines. Mol. Biol. Rep. 27, 113–121.
Hardy J. and Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353–356.
Huang X. (1996) An improved sequence assembly program. Genomics 33, 21–31.
Hussain I., Powell D., Howlett D. R., Tew D. G., Meek T. D., Chapman C., et al. (1999) Identification of a novel aspartic protease (Asp 2) as β-secretase. Mol. Cell. Neurosci. 14, 419–427.
Jeanmougin F., Thompson J. D., Gouy M., Higgins D. G., and Gibson T. J. (1998) Multiple sequence alignment with Clustal X. Trends Biochem. Sci. 23, 403–405.
Jurka J., Klonowski P., Dagman V., and Pelton P. (1996) CENSOR—a program for identification and elimination of repetitive elements from DNA sequences. Comput. Chem. 20, 119–122.
La Fauci G., Lahiri D. K., Salton S. R., and Robakis N. K. (1989) Characterization of the 5′-end region and the first two exons of the β-protein precursor gene. Biochem. Biophys. Res. Commun. 159, 297–304.
Lahiri D. K., Farlow M. R., Sambamurti K., Greig N. H., Giacobini E., and Schneider L. S. (2003) A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr. Drug Targets 4, 97–112.
Lahiri D. K., Maloney B., and Ge Y.-W. (2006) BACE1 gene promoter is differentially regulated: Detection of a novel promoter region for its cell type-specific regulation. J. Mol. Neurosci. 28(2), 193–210.
Lahiri D. K., Maloney B., and Ge Y.-W. (2006) Functional domains of the BACE1 and BACE2 promoters and mechanisms of transcriptional suppression of the BACE2 promoter in normal neuronal tissue. J. Mol. Neurosci. 29(1), 65–80.
Lahiri D. K., Song W., and Ge Y. W. (2000) Analysis of the 5′-flanking region of the β-amyloid precursor protein gene that contributes to increased promoter activity in differentiated neuronal cells. Brain Res. Mol. Brain Res. 77, 185–198.
Lin X., Koelsch G., Wu S., Downs D., Dashti A., and Tang J. (2000) Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein. Proc. Natl. Acad. Sci. U. S. A. 97, 1456–1460.
Motonaga K., Itoh M., Becker L. E., Goto Y. and Takashima S. (2002) Elevated expression of β-site amyloid precursor protein cleaving enzyme 2 in brains of patients with Down syndrome. Neurosci. Lett. 326, 64–66.
Nowotny P., Kwon J. M., Chakraverty S., Nowotny V., Morris J. C., and Goate A. M. (2001) Association studies using novel polymorphisms in BACE1 and BACE2. Neuroreport 12, 1799–1802.
Rice P., Longden I., and Bleasby A. (2000) EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 16, 276–277.
Rossner S., Apelt J., Schliebs R., Perez-Polo J. R., and Bigl V. (2001) Neuronal and glial β-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology. J. Neurosci. Res. 64, 437–446.
Sambamurti K., Kinsey R., Maloney B., Ge Y. W., and Lahiri D. K. (2004) Gene structure and organization of the human β-secretase (BACE) promoter. FASEB J. 18, 1034–1036.
Satoh J. and Kuroda Y. (2000) Amyloid precursor protein β-secretase (BACE) mRNA expression in human neural cell lines following induction of neuronal differentiation and exposure to cytokines and growth factors. Neuropathology 20, 289–296.
Solans A., Estivill X., and de La Luna, S. (2000) A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein β-secretase. Cytogenet. Cell Genet. 89, 177–184.
Strayer D., Heintz N., Roeder R., and Gillespie D. (1983) Three organizations of human DNA. Proc. Natl. Acad. Sci. U. S. A. 80, 4770–4774.
Sun X., Wang Y., Qing H., Christensen M. A., Liu Y., Zhou W., et al. (2005) Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes. FASEB J. 19, 739–749.
Vassar R., Bennett B. D., Babu-Khan S., Kahn S., Mendiaz E. A., Denis P., et al. (1999) β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, Science 286, 735–741.
Vattemi G., Engel W. K., McFerrin J., Buxbaum J. D., Pastorino L., and Askanas V. (2001) Presence of BACE1 and BACE2 in muscle fibres of patients with sporadic inclusion-body myositis. Lancet 358, 1962–1964.
Vattemi G., Engel W. K., McFerrin J., Pastorino L., Buxbaum J. D., and Askanas V. (2003) BACE1 and BACE2 in pathologic and normal human muscle. Exp. Neurol. 179, 150–158.
Watanabe H., Fujiyama A., Hattori M., Taylor T. D., Toyoda A., Kuroki Y., Noguchi H., et al. (2004) DNA sequence and comparative analysis of chimpanzee chromosome 22. Nature 429, 382–388.
Yan R., Bienkowski M. J., Shuck M. E., Miao H., Tory, M. C., Pauley A. M., et al. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity. Nature 402, 533–537.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maloney, B., Ge, YW., Greig, N.H. et al. Characterization of the human β-secretase 2 (BACE2) 5′-flanking region. J Mol Neurosci 29, 81–99 (2006). https://doi.org/10.1385/JMN:29:1:81
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:29:1:81